{"page":{"totalFilteredElements":53},"studies":[{"active":true,"description":"CESS-R-CESS Register","eudractNumber":null,"id":10263,"indications":[{"id":"sar","name":"Sarkome"},{"id":"sar1","name":"Knochensarkome (Ewing-Sarkom, Osteosarkom etc.)"},{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_12","name":"N/A"},"recruitmentStart":"2024-11-19T12:14:29+01:00","shortTitle":"CESS Registry","therapeutical":false,"therapyLines":[{"id":"tl_3","name":"Drittlinie"}]},{"active":true,"description":"<div>Protocol for standardized diagnostic procedures, registration, and treatment recommendations in children and adolescents with Philadelphia chromosome-positive chronic myeloid leukemia (CML)</div><div><br /></div><div><br /></div>","eudractNumber":null,"id":6082,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped1","name":"Leukämien"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[{"name":"ABL","id":"mt_203"},{"name":"bcr-abl","id":"mt_57"}],"nctNumber":null,"phase":null,"recruitmentStart":"2016-01-01T14:35:44+01:00","shortTitle":"CML-paed II Register","therapeutical":true,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"COSS Register [COSSIRP] <br />= Klinisches Register f&#252;r Kinder, Jugendliche \nund Erwachsene mit Osteosarkomen und Knochentumoren. Das COSS-Register \nbeinhaltet keine Vorgaben an Diagnostik oder Therapie. [s. Homepage der <b>C</b>ooperative <b>O</b>steo<b>S</b>arkom <b>S</b>tudiengruppe, <b>COSS</b>]<br />","eudractNumber":null,"id":948,"indications":[{"id":"sar","name":"Sarkome"},{"id":"sar1","name":"Knochensarkome (Ewing-Sarkom, Osteosarkom etc.)"},{"id":"sar2","name":"Weichteilsarkome (Liposarkom, Leiomyosarkom, etc.)"},{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2005-10-01T13:19:16+02:00","shortTitle":"COSS Register - COSSIRP","therapeutical":true,"therapyLines":[]},{"active":true,"description":"International CPT-SIOP-Registry<br />","eudractNumber":null,"id":1225,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped3","name":"Hirntumore (Tumore des zentralen Nervensystems)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2010-03-01T12:26:23+01:00","shortTitle":"CPT-SIOP Register","therapeutical":true,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"A multinational registry for rhabdoid tumors of any anatomical site / EU-RHAB-Register (AT/RT)","eudractNumber":null,"id":232,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped3","name":"Hirntumore (Tumore des zentralen Nervensystems)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2010-11-15T10:59:53+01:00","shortTitle":"EU-RHAB","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"Prospective non-randomized multi-center study for epidemiology and characterization of MDS and JMML in childhood<br /><b>ICD-10: C93.3</b><br />","eudractNumber":null,"id":133,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped1","name":"Leukämien"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":"NCT00662090","phase":null,"recruitmentStart":"2006-04-19T10:30:21+02:00","shortTitle":"EWOG-MDS 2006","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"<p>EWOG - SAA 2010</p><p>Genetische und immunologische Charakterisierung der erworbenen schweren aplastischen An&#228;mie (SAA) bei Kindern und Jugendlichen <br /></p>","eudractNumber":null,"id":1772,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2012-10-30T10:30:42+01:00","shortTitle":"EWOG-SAA 2010","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"Fanconi Anemia Registry 01","eudractNumber":null,"id":2355,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[{"name":"FANC (Fanconi anemia complementation group)","id":"mt_21"}],"nctNumber":null,"phase":null,"recruitmentStart":"2014-01-01T08:34:26+01:00","shortTitle":"Fanconi Anämie Register (FAR01)","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"GPOH HD Study Registry 2.0<div>Prospective Registry for children and adolescents with classical Hodgkin Lymphoma, nodular lymphocyte-predominant Hodgkin Lymphoma and relapsed Hodgkin Lymphoma<br /><div><br /></div></div>","eudractNumber":null,"id":10077,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped2","name":"Lymphome"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2024-10-07T09:34:03+02:00","shortTitle":"GPOH HD Study Registry 2.0","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"Register f&#252;r Lebertumoren bei Kindern und Jugendlichen<br />","eudractNumber":null,"id":698,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2011-01-01T09:26:41+01:00","shortTitle":"GPOH Lebertumorregister","therapeutical":true,"therapyLines":[]}]}